WallStreetZenWallStreetZen

NASDAQ: ENTX
Entera Bio Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their ENTX stock forecasts and price targets.

Forecast return on equity

Is ENTX forecast to generate an efficient return?

Company
-160.29%
Industry
71.5%
Market
262.89%
ENTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENTX forecast to generate an efficient return on assets?

Company
-143.81%
Industry
24.27%
ENTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENTX earnings per share forecast

What is ENTX's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.33
Avg 2 year Forecast
-$0.68

ENTX revenue forecast

What is ENTX's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$42.8k-80.79%
ENTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ENTX revenue growth forecast

How is ENTX forecast to perform vs Biotechnology companies and vs the US market?

Company
-80.79%
Industry
9,181.71%
Market
1,351.27%
ENTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ENTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ENTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTX$2.73N/AN/A
GLSI$9.15N/AN/A
SEER$2.22N/AN/A
AGEN$3.85$14.50+276.62%Buy
HURA$2.45$12.00+389.80%Buy
View Top Biotech Stocks

Entera Bio Stock Forecast FAQ

What is ENTX's earnings growth forecast for 2025-2026?

(NASDAQ: ENTX) Entera Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 119.69%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,754.17%.

Entera Bio's earnings in 2025 is -$10,091,000.On average, 3 Wall Street analysts forecast ENTX's earnings for 2025 to be -$14,835,587, with the lowest ENTX earnings forecast at -$14,253,800, and the highest ENTX earnings forecast at -$15,271,928.

In 2026, ENTX is forecast to generate -$31,062,011 in earnings, with the lowest earnings forecast at -$29,843,893 and the highest earnings forecast at -$31,975,599.

If you're new to stock investing, here's how to buy Entera Bio stock.

What is ENTX's revenue growth forecast for 2025-2025?

(NASDAQ: ENTX) Entera Bio's forecast annual revenue growth rate of -80.79% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 9,181.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,351.27%.

Entera Bio's revenue in 2025 is $223,000.

In 2025, ENTX is forecast to generate $1,947,171 in revenue, with the lowest revenue forecast at $1,870,811 and the highest revenue forecast at $2,004,441.

What is ENTX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ENTX) forecast ROA is -143.81%, which is lower than the forecast US Biotechnology industry average of 24.27%.

What is ENTX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ENTX) Entera Bio's current Earnings Per Share (EPS) is -$0.26. On average, analysts forecast that ENTX's EPS will be -$0.33 for 2025, with the lowest EPS forecast at -$0.31, and the highest EPS forecast at -$0.34. In 2026, ENTX's EPS is forecast to hit -$0.68 (min: -$0.66, max: -$0.70).

What is ENTX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ENTX) forecast ROE is -160.29%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.